Innocan Pharma Among Leading CBD Pharma Companies to Participate at Lytham Partners Summer 2021 Investor Conference
- Written by Newsfile
Iris Bincovich, CEO will participate on the "CBD Treatments" discussion panel on Monday June 14 at 11:00AM ET.
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 9, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), is pleased to announce that it will participate at the Lytham Partners...

